Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dunn

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Drug and Alcohol Dependence|May 23, 2026
Fentanyl overdose death rates are associated with regional differences in urine drug testing resultsAndrew S Huhn, Kelly E Dunn, Daniel Ciccarone, et al.
Experimental and Clinical Psychopharmacology|April 17, 2020
Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female ratsCassandra D Gipson, Kelly E Dunn, Amanda Bull, et al.
Experimental and Clinical Psychopharmacology|July 15, 2021
The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug puritySean B Dolan, Matthew W Johnson, Kelly E Dunn, et al.
Journal of Substance Abuse Treatment|December 24, 2017
Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSATPeter D Friedmann, Kelly E Dunn, Edward V Nunes, et al.
JAMA Psychiatry|July 13, 2017
Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical TrialKelly E Dunn, D Andrew Tompkins, George E Bigelow, et al.
Addictive Behaviors|July 24, 2017
Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patientsKelly E Dunn, Patrick H Finan, D Andrew Tompkins, et al.
Journal of Substance Abuse Treatment|August 3, 2019
Buprenorphine in the United States: Motives for abuse, misuse, and diversionHoward D Chilcoat, Halle R Amick, Molly R Sherwood, et al.
Journal of Addiction Medicine|January 12, 2019
Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid UseKaitlyn R Hay, Andrew S Huhn, David Andrew Tompkins, et al.
Drug and Alcohol Dependence|November 2, 2018
A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorderAndrew S Huhn, Eric C Strain, D Andrew Tompkins, et al.
Pain Medicine (Malden, Mass.)|January 29, 2019
Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid WithdrawalAndrew S Huhn, D Andrew Tompkins, Claudia M Campbell, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Drug and Alcohol Dependence|May 23, 2026
Fentanyl overdose death rates are associated with regional differences in urine drug testing resultsAndrew S Huhn, Kelly E Dunn, Daniel Ciccarone, et al.
Experimental and Clinical Psychopharmacology|April 17, 2020
Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female ratsCassandra D Gipson, Kelly E Dunn, Amanda Bull, et al.
Experimental and Clinical Psychopharmacology|July 15, 2021
The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug puritySean B Dolan, Matthew W Johnson, Kelly E Dunn, et al.
Journal of Substance Abuse Treatment|December 24, 2017
Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSATPeter D Friedmann, Kelly E Dunn, Edward V Nunes, et al.
JAMA Psychiatry|July 13, 2017
Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical TrialKelly E Dunn, D Andrew Tompkins, George E Bigelow, et al.
Addictive Behaviors|July 24, 2017
Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patientsKelly E Dunn, Patrick H Finan, D Andrew Tompkins, et al.
Journal of Substance Abuse Treatment|August 3, 2019
Buprenorphine in the United States: Motives for abuse, misuse, and diversionHoward D Chilcoat, Halle R Amick, Molly R Sherwood, et al.
Journal of Addiction Medicine|January 12, 2019
Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid UseKaitlyn R Hay, Andrew S Huhn, David Andrew Tompkins, et al.
Drug and Alcohol Dependence|November 2, 2018
A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorderAndrew S Huhn, Eric C Strain, D Andrew Tompkins, et al.
Pain Medicine (Malden, Mass.)|January 29, 2019
Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid WithdrawalAndrew S Huhn, D Andrew Tompkins, Claudia M Campbell, et al.
Pageof 17